CDKN2A and nasopharyngeal carcinoma: It is likely that EBV DNA load is related to CNV gain of CCND1 and loss of CDKN2A. In this situation, PAL, may block the cell cycle effectively in NPC tumors with a CCND1 amplification and CDKN2A deletion genetic background.